Morphic Therapeutic
USEntry
2023
Hold
1yr
Exit
2024
Who owns Morphic Therapeutic?
Morphic Therapeutic was owned by Novo Holdings through Novo Holdings Venture Investments (1999 vintage) from 2023 to 2024, exited via Trade Sale.
Buyer identity available on Pro.
Hand-verified · updated 2026-08-18
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2024
More from Novo Holdings Venture Investments
Other portfolio companies in the same fund.
Switzerland
SwedenMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Track Morphic Therapeutic
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Morphic Therapeutic?
7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Morphic Therapeutic.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue